Pet Diabetes Care Market Size & Growth Forecast 2026–2035, By Segments (Distribution Channel, Animal Type, Solution), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Pet Diabetes Care Market size was assessed at USD 2.24 Billion in 2025 and is poised to grow at a 9% CAGR between 2026 and 2035, exceeding USD 5.3 Billion by 2035. The industry revenue for 2026 is estimated at USD 2.41 billion.
Get more details on this report
Request Free Sample ReportPet Diabetes Care Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 42.40% share due to high pet ownership, strong disease awareness, established veterinary care systems, and consistent use of insulin therapy and glucose monitoring solutions.
- Asia Pacific is growing at 10.17% CAGR, supported by rising pet adoption, improving veterinary access, and increasing structured diagnosis and long-term management of pet diabetes conditions.
Segment Momentum
- Veterinary hospitals and clinics lead with 43.46% share in 2025 due to their central role in diagnosis, insulin initiation, and ongoing treatment supervision requiring professional veterinary oversight.
- Cats are the fastest-growing segment as improving veterinary awareness and owner willingness to manage feline metabolic conditions increases adoption of diagnostics, monitoring, and long-term diabetes care.
Market Expansion Drivers
- Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand.
- Growing pet insurance adoption improving affordability of long-term diabetic care solutions.
- Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Key companies in the pet diabetes care market include Zoetis Inc. (United States), Merck Animal Health (United States), Boehringer Ingelheim International GmbH (Germany), Becton, Dickinson and Company (United States), Nova Biomedical Corporation (United States), I-SENS, Inc. (South Korea), Allison Medical, Inc. (United States), Abbott Laboratories (United States), Elanco Animal Health Incorporated (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
A larger diagnosed population of diabetic pets is directly increasing the recurring care burden in the pet diabetes care market, since disease management depends on ongoing insulin therapy, glucose monitoring, syringes, test strips, prescription diets, and repeat veterinary consultations rather than one-time treatment. As obesity, aging, and other chronic conditions become more common in companion animals, veterinarians are screening more actively and initiating earlier treatment pathways, which raises product utilization over extended periods. This dynamic is encouraging market growth by shifting demand toward continuous disease management solutions and making adherence tools, monitoring systems, and reliable supply access more central to purchasing decisions.
Growing pet insurance adoption improving affordability of long-term diabetic care solutions
Wider pet insurance coverage is reducing the out-of-pocket barrier that often delays diagnosis, limits follow-up visits, or leads owners to choose only basic management options, creating a more stable treatment pathway in the pet diabetes care market. When reimbursement supports consultations, diagnostics, insulin prescriptions, and monitoring supplies, pet owners are more likely to accept long-term care plans and maintain consistent therapy over time. That change in spending behavior is influencing market adoption of higher-value diabetes management products, particularly monitoring devices and structured care regimens that require sustained financial commitment.
Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption
A growing pet population, combined with higher willingness to spend on animal health, is widening the addressable base for advanced care tools in the pet diabetes care market. As owners increasingly treat pets as long-term family companions, they are more receptive to technologies that help manage chronic disease at home and reduce uncertainty between veterinary visits. This is increasing demand for the market by improving acceptance of glucose monitoring devices and related consumables, while veterinary clinics are also more inclined to recommend these solutions when clients show greater readiness to invest in routine monitoring and better glycemic control.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of diabetes and chronic illnesses in companion animals increasing treatment demand | 2.00% | Moderate | North America, Europe | High | Near Term |
| Growing pet insurance adoption improving affordability of long-term diabetic care solutions | 1.70% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expanding companion animal ownership and veterinary healthcare spending strengthening monitoring device adoption | 1.40% | Low | Asia Pacific, Latin America | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional position in 2025, accounting for a 42.40% share of the pet diabetes care market. This leadership is backed by high companion animal ownership, broader awareness of chronic disease management in pets, and established veterinary care pathways that enable earlier diagnosis and consistent treatment. The region’s market activity is further aided by routine glucose monitoring, sustained use of insulin therapies, and stronger access to specialized veterinary services, all of which keep treatment adherence and product demand comparatively high.
Asia Pacific is projected to expand at a 10.17% CAGR over the forecast period in the pet diabetes care market, driven by rising pet adoption and improving access to veterinary services across urban centers. Growth is accelerating as more pet owners seek formal diagnosis and long-term management for companion animal health conditions, while veterinary infrastructure and availability of diabetes-related care products continue to improve. This is translating into broader uptake of monitoring tools and treatment regimens as animal healthcare spending becomes more structured across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Veterinary ManagementGermany prioritizes evidence-based veterinary diabetes care supported by advanced diagnostic practices and structured treatment protocols. German veterinary providers are integrating reliable monitoring technologies and tailored insulin therapies to strengthen chronic disease management for diabetic pets.
France 🇫🇷
Preventive Veterinary FocusFrance emphasizes earlier diagnosis and structured follow-up for diabetic companion animals through established veterinary care networks. French clinics continue incorporating modern glucose monitoring technologies to improve treatment planning and long-term patient outcomes.
Italy 🇮🇹
Specialized Clinical CareItaly is expanding access to specialized veterinary endocrinology services for companion animals requiring long-term diabetes management. Veterinary professionals in Italy are increasing the use of advanced diagnostics and individualized treatment plans to improve disease control.
Japan 🇯🇵
Aging Pet SupportJapan focuses on diabetes care solutions suited to its growing aging companion animal population. Veterinary practices in Japan are adopting minimally invasive monitoring methods and personalized treatment approaches that improve routine disease management for elderly pets.
South Korea 🇰🇷
Digital Veterinary AdoptionSouth Korea is strengthening pet diabetes management through connected veterinary services and growing acceptance of digital monitoring technologies. Companion animal clinics are expanding access to diagnostic tools and owner education that support more consistent diabetes care.
United States 🇺🇸
Advanced Companion CareThe U.S. market emphasizes continuous glucose monitoring, insulin management, and digital veterinary care for companion animals. Clinics across the U.S. are expanding preventive diabetes management services while pet owners increasingly seek convenient monitoring solutions that improve long-term treatment adherence.
Segment Leadership and Growth Trends
Pet Diabetes Care Market Share (%), Distribution Channel, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportVeterinary Hospitals & Clinics held a 43.46% share of the pet diabetes care market in 2025, reflecting their central role in diagnosis, insulin initiation, glucose monitoring, and ongoing treatment adjustment. This channel maintains leadership because pet diabetes care often depends on professional supervision, especially when dosage changes, device selection, and management of complications require direct veterinary involvement. Owners also tend to rely on clinics for trusted treatment recommendations and immediate access to prescription-led care, which helps sustain the segment’s leading share.
E-commerce is emerging as the fastest-growing distribution channel in the pet diabetes care market as pet owners increasingly shift routine purchasing of consumables and long-term care supplies to digital platforms. Its growth is reinforced through the convenience of repeat ordering, broader product visibility, and easier price comparison for items needed on an ongoing basis, such as monitoring accessories and diabetes management products. Compared with traditional offline channels, e-commerce is gaining momentum because it fits the recurring nature of pet diabetes care while reducing purchase friction for owners managing continuous treatment.
Animal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)
Within the pet diabetes care market, dogs accounted for the largest share in 2025, reinforced through consistent diagnosis and treatment engagement through veterinary care settings. The segment’s leadership is maintained through the structured care pathway often associated with canine diabetes management, where owners are more likely to pursue regular monitoring, insulin administration, and follow-up visits over extended periods. This pattern supports steady demand for diabetes care products and services across the dog population.
Cats represent the fastest-growing animal type in the pet diabetes care market, driven by rising attention to feline metabolic health and increasing treatment adoption among cat owners. Growth is gaining pace as veterinary awareness and owner willingness to manage chronic feline conditions improve, leading to greater uptake of diagnostics, glucose monitoring, and ongoing diabetes support. Relative to dogs, the cat segment is expanding faster because it is advancing from a lower base of treatment penetration and benefiting from improving recognition of care needs.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Distribution Channel | Veterinary Hospitals & Clinics, Retail Pharmacies, E-commerce | Veterinary Hospitals & Clinics | E-commerce |
| Animal Type | Dogs, Cats | Dogs | Cats |
| Solution | Treatment, Glucose Monitoring Devices | Treatment | Glucose Monitoring Devices |
Competitive Landscape and Market Positioning
1. Zoetis Inc. (United States)
2. Merck Animal Health (United States)
3. Boehringer Ingelheim International GmbH (Germany)
4. Becton Dickinson and Company (United States)
5. Nova Biomedical Corporation (United States)
6. I-SENS Inc. (South Korea)
7. Allison Medical Inc. (United States)
8. Abbott Laboratories (United States)
9. Elanco Animal Health Incorporated (United States)
Rising awareness regarding chronic pet health conditions is driving innovation in the pet diabetes care market. Manufacturers are introducing advanced glucose monitoring solutions, insulin delivery systems, and specialized nutritional products tailored for companion animals. Growing expenditure on veterinary healthcare and preventive treatment solutions is also encouraging continuous expansion of diabetes management offerings in the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Boehringer Ingelheim | Aug-23 | The FDA authorized SENVELGO (velagliflozin), a novel oral SGLT2 inhibitor for the management of feline diabetes. By offering a convenient once-daily liquid formulation, the drug represents a significant therapeutic innovation that reduces the frequency of insulin injections, addressing a critical compliance barrier in pet care and establishing a new standard for glucose regulation in diabetic cats. |
| Zoetis | Sep-22 | Zoetis acquired NewMetrica, a UK-based developer of health-related quality-of-life assessment tools for pets. This acquisition integrates specialized digital monitoring capabilities into Zoetis’s existing pet health portfolio, enabling more precise clinical assessment and improved outcomes for chronic condition management, including diabetes care, through advanced data-driven veterinary diagnostics. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Pet Diabetes Care Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Pet Diabetes Care Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the pet diabetes care market?
How much is the pet diabetes care industry expected to grow by 2035?
How is rising diabetes prevalence in companion animals impacting demand for long-term pet diabetes care?
What role is pet insurance playing in shaping treatment adoption in the pet diabetes care market?
Why are veterinary hospitals and clinics the leading distribution channel?
Why are cats the fastest-growing animal type in pet diabetes care?
Why is North America the leading region in pet diabetes care?
What is driving Asia Pacific growth in pet diabetes care?
Which companies are driving growth in the pet diabetes care landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization